Recruiting NA INTERVENTIONAL 3-arm NCT05868408

Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants

Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants: a Double-blind, Randomized, Controlled, Multi-arm Trial

Sponsor: Société des Produits Nestlé (SPN)

Conditions Growth and Development Infant Development Infant Formula Infant Health Infant Nutritional Physiological Phenomena

Interventions Control Formula Experimental Formula 1 Experimental Formula 2

Updated 6 times since 2023 Last updated: Dec 18, 2025 Started: Aug 17, 2023 Primary completion: Dec 31, 2027 Completion: Jun 30, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Growth and Development and Infant Development and is currently actively recruiting participants. Société des Produits Nestlé (SPN) leads this study, which shows 6 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Recruiting NA
Aug 2025 — Jan 2026 [monthly]

Recruiting NA
Sep 2024 — Aug 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Nov 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Jun 2023 — Nov 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Société des Produits Nestlé (SPN)

Data source: Société des Produits Nestlé (SPN)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jeddah, Saudi Arabia
• Riyadh, Saudi Arabia